Impact of Myocardial Fibrosis on Cardiovascular Structure, Function and Functional Status in Heart Failure with Preserved Ejection Fraction

被引:0
|
作者
Gavin A. Lewis
Anna Rosala-Hallas
Susanna Dodd
Erik B. Schelbert
Simon G. Williams
Colin Cunnington
Theresa McDonagh
Christopher A. Miller
机构
[1] University of Manchester,Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre
[2] Manchester University NHS Foundation Trust,Liverpool Clinical Trials Centre, Clinical Directorate, Faculty of Health and Life Sciences
[3] University of Liverpool (a member of Liverpool Health Partners),Department of Health Data Sciences, Institute of Population Health, Faculty of Health and Life Sciences
[4] Alder Hey Children’s NHS Foundation Trust,Department of Medicine
[5] University of Liverpool (a member of Liverpool Health Partners),Clinical and Translational Science Institute
[6] University of Pittsburgh School of Medicine,Wellcome Centre for Cell
[7] UPMC Cardiovascular Magnetic Resonance Center,Matrix Research, Division of Cell
[8] Heart and Vascular Institute,Matrix Biology & Regenerative Medicine, School of Biology, Faculty of Biology, Medicine & Health, Manchester Academic Health Science Centre
[9] University of Pittsburgh,undefined
[10] King’s College Hospital,undefined
[11] University of Manchester,undefined
来源
Journal of Cardiovascular Translational Research | 2022年 / 15卷
关键词
Heart failure with preserved ejection fraction; Myocardial fibrosis; Magnetic resonance imaging (MRI); Mediation analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1436 / 1443
页数:7
相关论文
共 50 条
  • [1] Impact of Myocardial Fibrosis on Cardiovascular Structure, Function and Functional Status in Heart Failure with Preserved Ejection Fraction
    Lewis, Gavin A.
    Rosala-Hallas, Anna
    Dodd, Susanna
    Schelbert, Erik B.
    Williams, Simon G.
    Cunnington, Colin
    McDonagh, Theresa
    Miller, Christopher A.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2022, 15 (06) : 1436 - 1443
  • [2] Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction
    Gori, Mauro
    Senni, Michele
    Gupta, Deepak K.
    Charytan, David M.
    Kraigher-Krainer, Elisabeth
    Pieske, Burkert
    Claggett, Brian
    Shah, Amil M.
    Santos, Angela B. S.
    Zile, Michael R.
    Voors, Adriaan A.
    McMurray, John J. V.
    Packer, Milton
    Bransford, Toni
    Lefkowitz, Martin
    Solomon, Scott D.
    EUROPEAN HEART JOURNAL, 2014, 35 (48) : 3442 - 3451
  • [3] Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction
    Gori, Mauro
    Lam, Carolyn S. P.
    Gupta, Deepak K.
    Santos, Angela B. S.
    Cheng, Susan
    Shah, Amil M.
    Claggett, Brian
    Zile, Michael R.
    Kraigher-Krainer, Elisabeth
    Pieske, Burkert
    Voors, Adriaan A.
    Packer, Milton
    Bransford, Toni
    Lefkowitz, Martin
    McMurray, John J. V.
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (05) : 535 - 542
  • [4] Effects of Kangdaxin on myocardial fibrosis in heart failure with preserved ejection fraction rats
    Wu, Xiang
    Zhang, Yingling
    Qiao, Jianfeng
    Li, Cuiyun
    Lin, Chao
    Xiong, Shangquan
    JOURNAL OF THORACIC DISEASE, 2022, 14 (04) : 1157 - 1163
  • [5] Spironolactone, fibrosis and heart failure with preserved ejection fraction
    Reddy, Yogesh N. V.
    Sundaram, Varun
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (09) : 1569 - 1572
  • [6] CMR to characterize myocardial structure and function in heart failure with preserved left ventricular ejection fraction
    Ipek, Rojda
    Holland, Jennifer
    Cramer, Mareike
    Rider, Oliver
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2024, 25 (11) : 1491 - 1504
  • [7] Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction
    Chang, Di
    Xu, Ting-Ting
    Zhang, Shi-Jun
    Cai, Yu
    Min, Shu-Dan
    Zhao, Zhen
    Lu, Chun-Qiang
    Wang, Yuan-Cheng
    Ju, Shenghong
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (23) : 2511 - 2521
  • [8] Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction
    Nishino, Masami
    Egami, Yasuyuki
    Kawanami, Shodai
    Sugae, Hiroki
    Ukita, Kohei
    Kawamura, Akito
    Nakamura, Hitoshi
    Yasumoto, Koji
    Tsuda, Masaki
    Okamoto, Naotaka
    Matsunaga-Lee, Yasuharu
    Yano, Masamichi
    Tanouchi, Jun
    Yamada, Takahisa
    Yasumura, Yoshio
    Seo, Masahiro
    Tamaki, Shunsuke
    Hayashi, Takaharu
    Nakagawa, Akito
    Nakagawa, Yusuke
    Sotomi, Yohei
    Nakatani, Daisaku
    Hikoso, Shungo
    Sakata, Yasushi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 378 : 55 - 63
  • [9] Heart Failure With Preserved Ejection Fraction
    Borlaug, Barry A.
    Sharma, Kavita
    Shah, Sanjiv J.
    Ho, Jennifer E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (18) : 1810 - 1834
  • [10] Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction
    Lewis, Gavin A.
    Rosala-Hallas, Anna
    Dodd, Susanna
    Schelbert, Erik B.
    Williams, Simon G.
    Cunnington, Colin
    McDonagh, Theresa
    Miller, Christopher A.
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2022, 38 (07) : 1569 - 1578